PUBLIC HEALTH IMPACTS OF PRECISION MEDICINE: BALANCING INNOVATION WITH ACCESSIBILITY
Main Article Content
Keywords
Precision medicine, healthcare disparities, chronic diseases, socioeconomic status, healthcare infrastructure
Abstract
Precision medicine (PM) holds significant potential for enhancing the management of chronic illnesses and inherited conditions. The access to PM is still inconsistent, especially among different geographic and socioeconomic demographics. This research investigates the efficiency, availability, and fairness of PM in addressing different health issues. A combination of qualitative and quantitative methods was used, integrating numerical data from hospital records, national health databases, and government statistics, with qualitative interviews conducted with healthcare providers and patients. Data from 500 individuals were examined, concentrating on cancer, long-term illnesses, and hereditary conditions. Quantitative analysis employed regression analysis and chi-square tests, whereas thematic analysis was utilized for qualitative data. The research revealed notable enhancements in survival rates and health results for patients, especially those with cancer. It was discovered that access to PM was restricted in rural regions and among low-income communities, emphasizing a technological gap in healthcare availability. Urban populations experienced greater access to PM, with differences associated with healthcare infrastructure and socioeconomic conditions. Although PM provides significant health advantages, its execution is hampered by unequal access. Policymakers should focus on enhancing healthcare facilities in underserved areas and guaranteeing fair access to PM for every demographic group.
References
2. Buckeridge, D. L. (2020). Precision, equity, and public health and epidemiology informatics–a scoping review. Yearbook of medical informatics, 29(01), 226-230.
3. Canedo, J. R., Miller, S. T., Myers, H. F., & Sanderson, M. (2019). Racial and ethnic differences in knowledge and attitudes about genetic testing in the US: systematic review. Journal of Genetic Counseling, 28(3), 587-601.
4. Çatıker, A., Özdil, K., Büyüksoy, G. D. B., & Öztürk, G. K. (2023). Nurses' Covid-19 Vaccine Hesitancy: A Qualitative Study. Middle Black Sea Journal of Health Science, 9(1), 111-124.
5. Carty, P. (2023). Economic evaluation to evidence-based policy: birth cohort testing for hepatitis C in Ireland (Doctoral dissertation, Royal College of Surgeons in Ireland).
6. Conteh, J. G. (2022). Residents Perceptions of Healthcare Disparities in Rural Sierra Leone. Walden University.
7. Duffy, D. J. (2016). Problems, challenges, and promises: perspectives on precision medicine. Briefings in Bioinformatics, 17(3), 494-504.
8. Feliciano Jr, B. Y. (2022). Precision Health 26. Clinical Informatics Study Guide: Text and Review, 391.
9. Ginsburg, G. S., & Phillips, K. A. (2018). Precision medicine: from science to value. Health Affairs, 37(5), 694-701.
10. Goetz, L. H., & Schork, N. J. (2018). Personalized medicine: motivation, challenges, and progress. Fertility and sterility, 109(6), 952-963.
11. Harrington, R. A., Califf, R. M., Balamurugan, A., Brown, N., Benjamin, R. M., Braund, W. E., ... & Joynt Maddox, K. E. (2020). Call to action: rural health: a presidential advisory from the American Heart Association and American Stroke Association. Circulation, 141(10), e615-e644.
12. Hayashi, A., Hong, J., & Iacobuzio-Donahue, C. A. (2021). The pancreatic cancer genome revisited. Nature Reviews Gastroenterology & hepatology, 18(7), 469-481.
13. Juengst, E., McGowan, M. L., Fishman, J. R., & Settersten Jr, R. A. (2016). From “personalized” to “precision” medicine: the ethical and social implications of rhetorical reform in genomic medicine. Hastings Center Report, 46(5), 21-33.
14. Kamaludin, M. F., Xavier, J. A., & Amin, M. (2024). Social entrepreneurship and sustainability: A conceptual framework. Journal of Social Entrepreneurship, 15(1), 26-49.
15. Khoury, M. J., Iademarco, M. F., & Riley, W. T. (2016). Precision public health for the era of precision medicine. American journal of preventive medicine, 50(3), 398.
16. Klein, M. E., Parvez, M. M., & Shin, J. G. (2017). Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. Journal of Pharmaceutical Sciences, 106(9), 2368-2379.
17. Li, C., Mowery, D. L., Ma, X., Yang, R., Vurgun, U., Hwang, S., ... & Becich, M. J. (2024). Realizing the potential of social determinants data in EHR systems: A scoping review of approaches for screening, linkage, extraction, analysis, and interventions. Journal of Clinical and Translational Science, 8(1), e147.
18. Musunuru, K., Arora, P., Cooke, J. P., Ferguson, J. F., Hershberger, R. E., Hickey, K. T., ... & MacRae, C. A. (2018). Interdisciplinary models for research and clinical endeavors in genomic medicine: a scientific statement from the American Heart Association. Circulation: Genomic and Precision Medicine, 11(6), e000046.
19. McNaughton, C. D., Cawthon, C., Kripalani, S., Liu, D., Storrow, A. B., & Roumie, C. L. (2015). Health literacy and mortality: a cohort study of patients hospitalized for acute heart failure. Journal of the American Heart Association, 4(5), e001799.
20. Purba, S. Y. (2024). Precision Medicine: Utilizing Genomic Insights for Customized Therapeutic Strategies. The Journal of Academic Science, 1(5), 497-504.
21. Pongdee, T., Brunner, W. M., Kanuga, M. J., Sussman, J. H., Wi, C. I., & Juhn, Y. J. (2023). Rural health disparities in allergy, asthma, and immunologic diseases: the current state and future direction for clinical care and research. The Journal of Allergy and Clinical Immunology: In Practice.
22. Pritchard, D. E., Moeckel, F., Villa, M. S., Housman, L. T., McCarty, C. A., & McLeod, H. L. (2017). Strategies for integrating personalized medicine into healthcare practice. Personalized medicine, 14(2), 141-152.
23. Vashisht, V., Vashisht, A., Mondal, A. K., Farmaha, J., Alptekin, A., Singh, H., ... & Kolhe, R. (2023). Genomics for emerging pathogen identification and monitoring: Prospects and obstacles. BioMedInformatics, 3(4), 1145-1177.
24. Wang, Q., Su, M., Zhang, M., & Li, R. (2021). Integrating digital technologies and public health to fight COVID-19 pandemic: key technologies, applications, challenges and outlook of digital healthcare. International Journal of Environmental Research and Public Health, 18(11), 6053.
25. Xu, J., Yang, P., Xue, S., Sharma, B., Sanchez-Martin, M., Wang, F., ... & Parikh, B. (2019). Translating cancer genomics into precision medicine with artificial intelligence: applications, challenges, and future perspectives. Human genetics, 138(2), 109-124.